NASDAQ:RNLX - US75973T1016 - ADR
Taking everything into account, RNLX scores 2 out of 10 in our fundamental rating. RNLX was compared to 35 industry peers in the Health Care Technology industry. RNLX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RNLX is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -109.75% | ||
ROE | -250.48% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 20.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.41 | ||
Debt/FCF | N/A | ||
Altman-Z | -5.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.76 | ||
Quick Ratio | 1.71 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.2071
+0.01 (+5.66%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 5.05 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.93 | ||
P/tB | 2.89 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -109.75% | ||
ROE | -250.48% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 20.6% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.41 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 0% | ||
Cap/Sales | 0% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.76 | ||
Quick Ratio | 1.71 | ||
Altman-Z | -5.75 |